News Announcement

Welcure Drugs & Pharmaceuticals: Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results For The Quarter/Year Ended 31St March 2026 Along With Statement Of Assets And Liabilities And Cash Flow Statement For The Year Ended 31St March 2026.

22-May-2026 Download PDF Welcure Drugs

Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Audited Financial Results for the quarter/year ended 31st March 2026 along with Statement of Assets and Liabilities and Cash Flow Statement for the year ended 31st March 2026.